SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 93 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2014. The put-call ratio across all filers is 1.91 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $65,000 | +124.1% | 29,096 | +94.0% | 0.00% | – |
Q1 2015 | $29,000 | -27.5% | 15,000 | 0.0% | 0.00% | – |
Q4 2014 | $40,000 | -11.1% | 15,000 | 0.0% | 0.00% | -100.0% |
Q3 2014 | $45,000 | -26.2% | 15,000 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $61,000 | -6.2% | 15,000 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $65,000 | – | 15,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 23,634,349 | $149,133,000 | 99.87% |
Perceptive Advisors | 4,762,472 | $30,052,000 | 1.24% |
QVT Financial LP | 1,750,285 | $11,044,000 | 0.75% |
NBW CAPITAL LLC | 404,721 | $2,554,000 | 0.45% |
Tekla Capital Management LLC | 489,750 | $3,090,000 | 0.34% |
MILES CAPITAL, INC. | 57,904 | $365,000 | 0.21% |
FULLER & THALER ASSET MANAGEMENT, INC. | 435,200 | $2,746,000 | 0.16% |
Old West Investment Management, LLC | 49,136 | $310,000 | 0.15% |
Integre Asset Management, LLC | 84,420 | $533,000 | 0.14% |
SABBY MANAGEMENT, LLC | 250,952 | $1,584,000 | 0.10% |